COMMUNIQUÉS West-GlobeNewswire

Erratum: Correction of press release published on April 7th, 2026
09/04/2026
The press release published on April 7 th , related to the acquisition of own shares, contained the following errors: In the third paragraph, the number of repurchased shares shall read “32,000” instead of “16,000”; In [...]
USA Today Names Aledade a 2026 Top Workplace for People-First Culture
09/04/2026
National award honors Aledade’s commitment to employee engagement and its mission-driven approach to advancing value-based care BETHESDA, Md., April 09, 2026 (GLOBE NEWSWIRE) -- Aledade , a physician-led, national [...]
Cynet Named Leader and Outperformer in 2026 GigaOm Radar for Extended Detection and Response (XDR)
09/04/2026
BOSTON, April 09, 2026 (GLOBE NEWSWIRE) -- Cynet, the unified, AI-powered cybersecurity platform empowering organizations to focus on what matters most, has been named a Leader and Outperformer in the 2026 GigaOm Radar [...]
SOUND Behavioral Health Celebrates 60 Years of Service and Leadership in King County
09/04/2026
SEATTLE, April 09, 2026 (GLOBE NEWSWIRE) -- This year, SOUND Behavioral Health celebrates a remarkable milestone: 60 years of serving the people of King County with transformative mental health care, while standing with [...]
Biodesix Recognized as a Top Workplace for Third Consecutive Year
09/04/2026
Employee-Driven, Prestigious National Recognition for the Consistently High-Performing Biodesix Culture LOUISVILLE, Colo., April 09, 2026 (GLOBE NEWSWIRE) -- Biodesix is proud to announce that it has earned the [...]
BCAN Names Ferring Pharmaceuticals and the Astellas/Pfizer Alliance as National Presenting Sponsors of the 2026 Walks to End Bladder Cancer
09/04/2026
Partnerships fuel awareness, research and support for people impacted by bladder cancer Bethesda, MD, April 09, 2026 (GLOBE NEWSWIRE) -- The Bladder Cancer Advocacy Network (BCAN) today announced that Ferring [...]
Zentalis Pharmaceuticals Announces 400mg QD 5:2 Azenosertib Monotherapy as the Pivotal Study Dose in Cyclin E1-Positive Platinum-Resistant Ovarian Cancer
09/04/2026
Planned interim analysis from DENALI Part 2a showed a clearly differentiated response rate at 400mg QD 5:2 over 300mg QD 5:2 and comparable safety profiles between the two dose groups Azenosertib therapeutic profile [...]
The Growing Connection Between Microplastics and the Human Heart
09/04/2026
Anathapindika Founder Speaks to Need for Detoxification in Supplementation: “Adding More Nutrients to Our Diets Is Not Enough for Healthy Living” Fort Lauderdale, FL, April 09, 2026 (GLOBE NEWSWIRE) -- The presence of [...]
Rhythm Pharmaceuticals to Report First Quarter 2026 Financial Results on Tuesday, May 5, 2026
09/04/2026
BOSTON, April 09, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine [...]
Nautilus Biotechnology to Announce First Quarter 2026 Financial Results on April 28, 2026
09/04/2026
SEATTLE, April 09, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced it will report financial results [...]
Noom and b.well Partner to Launch Integrated Health Record Access for Medicare Members
09/04/2026
New integration delivers on Noom's pledge to the CMS Health Technology Ecosystem initiative to enable deeper personalization within Noom’s diabetes and obesity programs PRINCETON, N.J., April 09, 2026 (GLOBE NEWSWIRE [...]
Seer and Precision Health Research, Singapore Sign Collaboration to Provide Deep, Unbiased Proteomics on 10,000 PRECISE SG100K Samples
09/04/2026
Seer’s Proteograph will be used to generate enhanced proteomic insights in one of the world’s largest multi-omic health studies REDWOOD CITY, Calif., April 09, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the [...]
Kestra Medical Technologies Named a 2026 USA TODAY Top Workplaces Award Winner
09/04/2026
KIRKLAND, Wash., April 09, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today announced it has been named a 2026 USA TODAY [...]
Cloudbreak Pharma Announces Launch of Cloudbreakpharma.com to Raise Awareness of its Pipeline of Novel First-in-Class Therapeutics to Treat Serious Underserved Ophthalmic Diseases
09/04/2026
Lead candidate, CBT-001 for the treatment of pterygium, a multi-billion-dollar addressable market, is in mid-Phase 3 with initial topline data anticipated in Q3 2026 Second asset, CBT-004 for the treatment of pinguecula [...]
Amneal Launches Bimatoprost Ophthalmic Solution, 0.01%
09/04/2026
Important ophthalmic treatment expected to be an important growth driver for Amneal’s Affordable Medicines segment BRIDGEWATER, N.J., April 09, 2026 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the “ [...]
Cerevance to Present Positive Phase 2 Solengepras Data in Parkinson’s Disease at the American Academy of Neurology 2026 Annual Meeting
09/04/2026
Solengepras, a once-daily, oral, non-dopaminergic GPR6 inhibitor, demonstrated meaningful reductions in daily OFF time and improvements in sleep-related symptoms across two Phase 2 trials Meeting presentations highlight [...]
Alignment Healthcare to Announce First Quarter 2026 Financial Results and Host Conference Call Thursday, April 30, 2026
09/04/2026
ORANGE, Calif., April 09, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), will release its first quarter 2026 financial results on Thursday, April 30, 2026, after market close. Following the release [...]
Boehringer Ingelheim to evaluate innovative combination of DLL3‑targeting T‑cell engager plus PD‑L1/VEGF‑A bispecific antibody in small cell lung cancer
09/04/2026
Clinical trial collaboration and supply agreement between Boehringer and BioNTech to conduct a Phase Ib/II clinical trial to explore complementary immuno-oncology mechanisms in extensive‑stage small cell lung cancer. [...]
Kyverna Therapeutics to Host Conference Call on New Data Across Neuroimmunology Franchise at AAN 2026
09/04/2026
EMERYVILLE, Calif., April 09, 2026 (GLOBE NEWSWIRE) -- Kyverna Therapeutics, Inc. (Kyverna, Nasdaq: KYTX), a late-stage clinical biopharmaceutical company focused on developing cell therapies for patients with [...]

Pages